Stem Cell Rev Rep 2020 Feb 01
Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies.
Wada M, Zhang H, Fang L, Feng J, Tse CO, Zhang W, Chen Q, Sha S, Cao Y, Chen KH, Pinz KG, Chen X, Fan XX, Jiang X, Ma Y
T-cell malignancies often result in poor prognosis and outcome for patients. Immunotherapy has recently emerged as a revolutionary treatment against c ...
Read More
Source: PubMed
Med. Oncol.
To be or not to be: whether anti-angiogenic agent combined with immune checkpoint inhibitoris necessary in the treatment of advanced or metastatic renal cell carcinoma.
Sun L, Zhang L, Yu J, Zhou Y, Shi C, Wasan HS, Ruan S, Huang D
Although it's widely known that targeted therapy against angiogenesis and immunotherapy agents showed survival benefit over chemoradiotherapy in advan ...
Read More
Source: PubMed
Dig. Dis. Sci. 2020 Feb 01
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.
DuPont HL, Jiang ZD, DuPont AW, Utay NS
Reduction in diversity of the intestinal microbiome (dysbiosis) is being identified in many disease states, and studies are showing important biologic ...
Read More
Source: PubMed
Curr Oncol Rep
Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
Jiang DM, Chung P, Kulkarni GS, Sridhar SS
Bladder-sparing trimodality therapy (TMT) has become an accepted alternative to cystectomy for selected muscle invasive bladder cancer (MIBC) patients ...
Read More
Source: PubMed
Biomed. Pharmacother.
Quercetin promotes the survival of granulocytic myeloid-derived suppressor cells via the ESR2/STAT3 signaling pathway.
Ma Z, Xia Y, Hu C, Yu M, Yi H
Quercetin is a natural product that has been shown to induce tumor apoptosis and necrosis through multiple mechanisms. Tumor-induced myeloid-derived s ...
Read More
Source: PubMed
